Verve Therapeutics Inc
General ticker "VERV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $502.7M
Verve Therapeutics Inc does not follow the US Stock Market performance with the rate: -22.5%.
Estimated limits based on current volatility of 5.9%: low 5.04$, high 5.68$
Factors to consider:
- Current price 29.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.33$, 19.68$]
- 2024-12-30 to 2025-12-30 estimated range: [7.91$, 18.59$]
Financial Metrics affecting the VERV estimates:
- Negative: Non-GAAP EPS, $ of -3.12 <= 0.10
- Negative: Operating profit margin, % of -94.99 <= 1.03
- Negative: Operating cash flow per share per price, % of -15.34 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term VERV quotes
Long-term VERV plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $1.94MM | $11.76MM |
| Operating Expenses | $87.07MM | $167.63MM | $234.88MM |
| Operating Income | $-87.07MM | $-165.69MM | $-223.12MM |
| Non-Operating Income | $-33.25MM | $8.35MM | $23.33MM |
| R&D Expense | $68.20MM | $130.09MM | $184.95MM |
| Income(Loss) | $-120.31MM | $-157.33MM | $-199.79MM |
| Taxes | $0.00MM | $0.05MM | $0.28MM |
| Profit(Loss) | $-120.31MM | $-157.39MM | $-200.07MM |
| Stockholders Equity | $357.35MM | $550.93MM | $599.50MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $384.12MM | $679.22MM | $752.69MM |
| Operating Cash Flow | $-77.88MM | $-122.33MM | $-149.55MM |
| Capital expenditure | $4.36MM | $13.23MM | $9.28MM |
| Investing Cash Flow | $-239.10MM | $-155.96MM | $27.69MM |
| Financing Cash Flow | $377.09MM | $328.96MM | $212.58MM |
| Earnings Per Share* | $-2.45 | $-2.91 | $-3.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.